Moat Ross bought KNSA

September 1, 2025 · Form 4 insider transaction

Moat Ross bought 2,477 shares of Kiniksa Pharmaceuticals Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

2,477

Price

N/A

Total value

N/A

InsiderMoat Ross

RoleOfficer

CompanyKiniksa Pharmaceuticals Ltd. (KNSA)

SecurityClass A Ordinary Share

Transaction codeM — Option exercise

Transaction dateSeptember 1, 2025

Filing dateSeptember 3, 2025

Shares owned after15,244

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

View the original Form 4 on SEC EDGAR